Insiders · PHAT

Heidi Fields

Director at Phathom Pharmaceuticals, Inc. (PHAT)

Heidi Fields has filed 17 insider reports with the SEC since March 2021, as director at Phathom Pharmaceuticals, Inc. (PHAT), director at Agilent Technologies, Inc. (A) and insider at Icosavax, Inc. (ICVX). Heidi Fields made no open-market purchases or sales in the last 12 months. The latest filing, on May 21, 2026, reports grant or award at Phathom Pharmaceuticals, Inc. (PHAT).

Filings
17
Companies
3
Bought on market
None
Sold on market
$806K

Companies where Heidi Fields is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Phathom Pharmaceuticals, Inc. logo
PHAT
Phathom Pharmaceuticals, Inc.
Director54,122$5.88May 21, 2026
Agilent Technologies, Inc. logo
A
Agilent Technologies, Inc.
Director$806K$172.92Mar 18, 2025
Icosavax, Inc. logo
ICVX
Icosavax, Inc.
Insider0Feb 21, 2024

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Heidi Fields with

Other insiders at the same companies

Questions about Heidi Fields

What is Heidi Fields's role at Phathom Pharmaceuticals, Inc.?
Heidi Fields reports to the SEC as director at Phathom Pharmaceuticals, Inc. (PHAT), according to the latest filing on May 21, 2026. Heidi Fields has also filed as director at Agilent Technologies, Inc. (A) and insider at Icosavax, Inc. (ICVX).
How many shares does Heidi Fields own?
After the latest filing that states it, Heidi Fields directly owned 54,122 shares of Phathom Pharmaceuticals, Inc. (PHAT). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Heidi Fields bought or sold stock recently?
The most recent open-market sale was on March 5, 2024: sold 1,658 shares of Agilent Technologies, Inc. (A) for $239K at an average of $144.34.
How do I get alerts when Heidi Fields files?
Follow Heidi Fields on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Heidi Fields (SEC CIK 0001014330). Totals count each trade once, skipping amendments whose original is on file, from Mar 22, 2021 on. View on SEC EDGAR